Viewing Study NCT01040832


Ignite Creation Date: 2025-12-24 @ 9:47 PM
Ignite Modification Date: 2025-12-25 @ 7:26 PM
Study NCT ID: NCT01040832
Status: COMPLETED
Last Update Posted: 2017-01-30
First Post: 2009-12-29
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: EMD 1201081 in Combination With Cetuximab in Second-Line Cetuximab-Naïve Subjects With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Sponsor: EMD Serono
Organization: